Clinical TrialsSearch results
Number of results: 340
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase 2 study of induction and early consolidation therapy for acute lymphoblastic leukemia in children (TCCSG ALL L04-16).
- Acute Lymphoblastic Leukemia
- Tokyo Children's Cancer Study Group
- 2008-10-05
Completed
- Favipiravir in patients infected with COVID-19
- patients infected with COVID-19
- Tokue Yutaka
- 2020-02-27
Completed
- Triple combination therapy in patients infected with COVID-19
- patients infected with COVID-19
- Tokue Yutaka
- 2020-02-27
Recruiting
- A Phase III study of Isotretinoin
- Severe Recalcitrant Acne
- Toida Tsuneyuki
- 2024-10-11
Other
- Non-randomized, multicenter, open, fixed-dose, single group, joint study to determine the efficacy and safety of Maoto for Influenza
- Influenza Type A and Type B
- TJ-27 Influenza study group
- 2008-11-21
Other
- Randomized trial of platinum based combination chemotherapy with or without Zoledronic acid as first line therapy for non-small cell lung cancer with bone metastases stratified by bone marker (TORG0706).
- Non-small cell carcinoma
- Thoracic Oncology Research Group (TORG)
- 2009-05-01
Other
- Phase I/II Study of Docetaxel and S-1 Combination Therapy for Advanced Non-small Cell Lung Cancer
- Advanced Non-small Cell Lung Cancer
- The Tokyo Cooperative Oncology Group
- 2005-11-14
Other
- Phase II Study of bi-weekly Paclitaxel (TAXOL)for fluorouracil resistant advanced and recurrent Gastric Cancer
- 5-fluorouracil resistant advanced and recurrent Gastric Cancer
- The Tokyo Cooperative Oncology Group
- 2005-11-18
Other
- Phase III randomized comparative study of combination therapy with CDDP and TS-1 vs. combination therapy with CDDP and Docetaxel in stage IIIB/IV non-small cell lung cancer
- Stage IIIB/IV or ppstoperative recurrent non-small sell lung cancer
- The Tokyo cooperative oncology group
- 2007-04-01
Other
- Randomized Phase III Trial of Irinotecan plus Cisplatin vs. bi-weekly Irinotecan after S-1 failure for Patients with Advanced and Recurrent Gastric Cancer
- S-1 failure for Patients with Advanced and Recurrent Gastric Cancer
- The Tokyo cooperative oncology group
- 2008-04-01